Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,588.00    22.00 (0.48%)
Bid:
4,586.00
Ask:
4,590.00
Spread: 4.00 (0.087%)
Market Cap: £16.72b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Directorate Change

21 Jun 2017 09:26

RNS Number : 7109I
Coca-Cola HBC AG
21 June 2017
 

FOR IMMEDIATE RELEASE

 

Coca-Cola HBC AG

Composition of the Committees of the Board of Directors of Coca‑Cola HBC AG and determination of a new member of the Board of Directors of Coca‑Cola HBC AG

 

 

Zug, Switzerland - 21 June 2017 - Coca‑Cola HBC AG ("Coca‑Cola HBC" or the "Company") announces today that its board of directors (the "Board") has appointed Ms. Charlotte J. Boyle as a member of the Remuneration Committee, with effect from 20 June 2017.

This appointment has been made pursuant to the announcement released by Coca‑Cola HBC on 15 May 2017 and the election of Ms. Charlotte J. Boyle as a non-executive member of the Board at the Company's annual general meeting held on 20 June 2017, following the retirement of Mr. Antonio D'Amato.

The Board has determined that Ms. Charlotte J. Boyle qualifies as independent under the criteria set forth in the UK Corporate Governance Code.

Aside from the information set out above, no further information is required to be disclosed pursuant to the UK Financial Conduct Authority's Listing Rule 9.6.13 and the new non-executive director does not hold any interests in the shares of Coca‑Cola HBC.

The composition of the Board Committees will be as follows:

Audit Committee

William (Bill) W. Douglas III (Chair)

John P. Sechi

Olusola (Sola) David-Borha

Nomination Committee

Reto Francioni (Chair)

Charlotte J. Boyle

Alexandra Papalexopoulou

Remuneration Committee

Alexandra Papalexopoulou (Chair)

Charlotte J. Boyle

Reto Francioni

Social Responsibility Committee

Anastasios I. Leventis (Chair)

Alexandra Papalexopoulou

José Octavio Reyes

This announcement is made pursuant to Listing Rule 9.6.11.

 

 

 

Enquiries

Coca‑Cola HBC Group

Basak Kotler

Investor Relations Director

Tel: +44 20 37 444 231 basak.kotler@cchellenic.com

Vasso Aliferi

Investor Relations Manager

Tel: +30 210 6183 341

vasso.aliferi@cchellenic.com

Maria Livaniou

Head of Shareowner Service

Tel: +30 210 6183 106

maria.livaniou@cchellenic.com

 

International media contact:

Teneo Blue Rubicon

Rob Morgan

Anushka Mathew

Tel: +44 20 7260 2700 robert.morgan@teneobluerubicon.com anushka.mathew@teneobluerubicon.com

 

Greek media contact:

V+O Communications

Argyro Oikonomou

Tel: +30 211 7501219

 ao@vando.gr

 

 

About Coca‑Cola HBC

Coca-Cola HBC is a leading bottler of The Coca-Cola Company with a sales volume of more than 2 billion unit cases. It has a broad geographic footprint with operations in 28 countries serving a population of approximately 595 million people. Coca-Cola HBC offers a diverse range of non-alcoholic ready to drink beverages in the sparkling, juice, water, sport, energy, tea and coffee categories. Coca-Cola HBC is committed to promoting sustainable development in order to create value for its business and for society. This includes providing products that meet the beverage needs of consumers, fostering an open and inclusive work environment, conducting its business in ways that protect and preserve the environment and contribute to the socio-economic development of the local communities. Coca-Cola HBC is ranked beverage industry leader in the Dow Jones Sustainability World and Europe Indices, and is also included in the FTSE4Good Index.

 

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and its shares are listed on the Athens Exchange (ATHEX: EEE). For more information, please visit http://www.coca-colahellenic.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALIFFTRSILFID
Date   Source Headline
1st Feb 20231:50 pmRNSIssue of equity and total voting rights
18th Jan 20232:47 pmRNSDirector/PDMR Shareholding
17th Jan 20239:34 amRNSNotice of Results
5th Jan 202310:14 amRNSAthens Exchange trading date of ordinary shares
4th Jan 20233:02 pmRNSDirector/PDMR Shareholding
20th Dec 202210:16 amRNSPost 2022 AGM Shareholder Engagement
19th Dec 20223:03 pmRNSDirector/PDMR Shareholding
1st Dec 20227:44 amRNSIssue of equity and total voting rights
18th Nov 20223:13 pmRNSDirector/PDMR Shareholding
17th Nov 20228:41 amRNSDirector/PDMR Shareholding
16th Nov 20225:06 pmRNSDirector/PDMR Shareholding
14th Nov 20222:36 pmRNSDirector/PDMR Shareholding
11th Nov 20221:32 pmRNSDirector/PDMR Shareholding
11th Nov 20221:24 pmRNSDirector/PDMR Shareholding
8th Nov 20227:00 amRNSContinued positive momentum
1st Nov 20222:50 pmRNSBlock listing Interim Review
18th Oct 20223:05 pmRNSDirector/PDMR Shareholding
13th Oct 202210:40 amRNSNotice of Results
3rd Oct 202210:03 amRNSIssue of equity and total voting rights
28th Sep 20221:28 pmRNSDirector/PDMR Shareholding
21st Sep 20225:07 pmRNSIssue of Debt
20th Sep 202211:51 amRNSDirector/PDMR Shareholding
16th Sep 202212:32 pmRNS2022 Performance Share Plan Awards
15th Sep 20225:21 pmRNSIssue of Debt
15th Sep 20222:44 pmRNSHolding(s) in Company
15th Sep 20228:49 amRNSIssue of Debt
13th Sep 202212:38 pmRNSDirector/PDMR Shareholding
7th Sep 202212:05 pmRNSHolding(s) in Company
6th Sep 20222:03 pmRNSPublication of a Prospectus
30th Aug 20229:14 amRNSHolding(s) in Company
25th Aug 20229:01 amRNSHolding(s) in Company
23rd Aug 20221:45 pmRNSHolding(s) in Company
23rd Aug 202211:06 amRNSHolding(s) in Company
18th Aug 20223:43 pmRNSHolding(s) in Company
18th Aug 202212:05 pmRNSHolding(s) in Company
18th Aug 202211:24 amRNSDirector/PDMR Shareholding
11th Aug 202212:40 pmRNSHolding(s) in Company
11th Aug 20227:00 amRNSStrong volumes, revenue, EBIT; investing in growth
9th Aug 20221:45 pmRNSDirector/PDMR Shareholding
9th Aug 20227:00 amRNSCCH agrees to acquire Three Cents
19th Jul 202212:53 pmRNSDirector/PDMR Shareholding
19th Jul 202210:48 amRNSNotice of Results
22nd Jun 202210:45 amRNSHolding(s) in Company
21st Jun 20224:28 pmRNSResult of AGM
20th Jun 20222:38 pmRNSDirector/PDMR Shareholding
8th Jun 20221:02 pmRNSAthens Exchange trading date of ordinary shares
6th Jun 20229:32 amRNSHolding(s) in Company
1st Jun 202210:02 amRNSIssue of Equity
31st May 20225:17 pmRNSLetter to shareholders
19th May 20229:20 amRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.